首页> 外文期刊>European review for medical and pharmacological sciences. >Correlation between intestinal flora and serum inflammatory factors in patients with Crohn’s disease
【24h】

Correlation between intestinal flora and serum inflammatory factors in patients with Crohn’s disease

机译:克罗恩病患者肠道菌群与血清炎症因子的相关性

获取原文
           

摘要

OBJECTIVE: We investigated the correlation between intestinal flora and serum inflammatory factors in patients with Crohn’s disease. PATIENTS AND METHODS: From February 2014 to June 2016, 132 patients with Crohn’s were enrolled in this study. There were 84 males and 48 females. The age range was from 28 to 72 years. We had 62 patients in active stage (the activity group) and 70 patients in remission stage (the remission group). We also enrolled 71 healthy cases in the control group. The expression levels of serum inflammatory factors including IL-6, IL-17, IL-22, and IL-33 were measured using ELISA. Fresh feces samples were diluted and, after cultivating the bacteria for 48 hours at 37°C, the number of colonies was counted. The number of flora per gram of feces (CFU/g) was determined. RESULTS: The number of Escherichia coli and Enterococcus sp. in feces was significantly higher in the activity group compared to that of the control group and the remission group. The levels IL-1, IL-17, L-22, and IL-33 in the activity group were significantly higher than those of other groups. The number of Escherichia coli and Enterococcus sp. was positively correlated with the levels of IL-6, IL-17, IL-22, and IL-33, while the number of Bifidobacteria and Bacillus lactic acid was negatively correlated with the levels of IL-6, IL-17, IL-22, and IL-33. CONCLUSIONS: The number of conditional pathogenic bacteria in the activity group, was higher than other groups, while the number of probiotics bacteria decreased distinctly. We concluded that monitoring the changes in distribution and composition of intestinal flora as well as the levels of blood inflammatory factors could play a significant role in the treatment process of Crohn’s disease.
机译:目的:我们研究了克罗恩病患者肠道菌群与血清炎症因子的相关性。患者与方法:2014年2月至2016年6月,该研究招募了132例克罗恩病患者。男84例,女48例。年龄范围是28至72岁。我们有62例处于活动期(活动组),而70例处于缓解期(缓解组)。我们还在对照组中纳入了71例健康病例。使用ELISA测量血清炎性因子包括IL-6,IL-17,IL-22和IL-33的表达水平。稀释新鲜的粪便样品,并在37℃下培养细菌48小时后,计数菌落数。确定每克粪便中的菌群数(CFU / g)。结果:大肠杆菌和肠球菌的数量。与对照组和缓解组相比,活动组的粪便中粪便的含量明显更高。活动组的IL-1,IL-17,L-22和IL-33水平显着高于其他组。大肠杆菌和肠球菌的数量。与IL-6,IL-17,IL-22和IL-33呈正相关,而双歧杆菌和芽孢杆菌乳酸的数量与IL-6,IL-17,IL-33呈负相关。 22和IL-33。结论:活动组中条件致病菌的数量高于其他组,而益生菌的数量则明显减少。我们得出的结论是,监测肠道菌群分布和组成的变化以及血液炎症因子的水平可能在克罗恩病的治疗过程中起重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号